ClinConnect ClinConnect Logo
Search / Trial NCT06685419

Propolis Containing Chewing Gum and Gingivitis

Launched by NAKSAKA · Nov 11, 2024

Trial Information

Current as of June 01, 2025

Completed

Keywords

Propolis Gingivitis Oral Health

ClinConnect Summary

Plaque is the primary etiological factor of periodontal diseases and as a result, inflammation of the gingiva can clinically lead to irreversible consequences such as bone and attachment loss and even tooth loss. Removing the plaque is the most important criterion in preventing inflammation. Plaque should be removed by brushing and the use of interface cleansing agents such as dental floss. However, it has been reported in studies that manually brushing teeth reduces plaque by 70%.

Propolis, which has anti-inflammatory effects, has been used for years in the treatment of infections and wou...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Systemically healthy
  • Has at least 20 teeth in his/her mouth.
  • Exclusion Criteria:
  • Smokers
  • ongoing orthodontic treatment
  • Allergy to the honey and honey-bee products
  • periodontal therapy in the last 6 months.
  • Pregnancy and breastfeeding
  • Use of antibiotics or another drugs in the last three months,
  • Presence of subgingival caries or infection that will affect brushing
  • Patients who were not willing to participate in the study

About Naksaka

Naksaka is a pioneering clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a commitment to enhancing patient outcomes, Naksaka specializes in the design and management of clinical trials across various therapeutic areas. Our team of experienced professionals collaborates closely with regulatory bodies, healthcare providers, and research institutions to ensure the highest standards of safety, efficacy, and compliance. By leveraging cutting-edge methodologies and a patient-centric approach, Naksaka aims to accelerate the delivery of groundbreaking therapies to market, ultimately improving the quality of life for patients worldwide.

Locations

Istanbul, Esenler, Turkey

Patients applied

0 patients applied

Trial Officials

Nurcan Altas

Principal Investigator

Istanbul Medipol Univeristy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported